News on Novartis (Ticker: NVS) continually updated from thousands of sources around the net.
1 hr ago | Fortune
The year-to-date level of announced M&A activity in the healthcare sector is at its highest level since Thomson Reuters began tracking such deals in 1980, hitting $153.5 billion.
Trending on the Topix Network
6 hrs ago | MediaPost
As part of an ongoing trend for pharmaceutical companies to get back to their knitting, Novartis and GlaxoSmithKline "agreed to trade more than $20 billion worth of assets on Tuesday to bolster their best businesses and exit weaker ones," as Reuters' Caroline Copley and Paul Sandle put it .
10 hrs ago | SFGate
The Jan. 29, 2014 file photo shows Novartis CEO Joseph Jimenez as he arrives for the annual balance press conference in Basel, Switzerland.
GlaxoSmithKline might be laying workers off but, others are hiring too! Check it out! GlaxoSmithKline's mutlibillion-dollar deal with Novartis announced Tuesday morning is expected to impact the drug company's workers in western Montgomery County the most.
Novartis and GlaxoSmithKline exchanged more than $20 billion in assets recently to reinforce their profitable divisions and eliminate their weaker businesses as drug manufacturers adjust to competition from generics and spending cuts in healthcare.
Plans for pharmaceutical giants Novartis , GlaxoSmithKline and Eli Lilly to swap business lines may have shaken up the stock market Tuesday, but work at a Novartis flu vaccine plant in Holly Springs hummed along, and local officials said they expect it to remain that way.
U.S. stocks rose on Tuesday as a host of solid earnings reports, along with strength in the healthcare sector, helped lift the S&P 500 and Nasdaq to their sixth straight advance.
We are proud of the progress we have made and this achievement inspires us to continue this important effort."
When the asset swap between GlaxoSmithKline , Novartis and Eli Lilly goes through in the first part of next year, each company says it will generate a larger portion of its overall revenue from its key focus areas.
Joe Jimenez, CEO of Swiss drug maker Novartis, gestures during an interview with Reuters at the company's headquarters in Basel in this March 19, 2014 file photo.
Novartis and Glaxo rose on the stock market today , while Lilly slipped a fraction.
Yesterday in a move that returned attention to healthcare takeovers, Bill Ackman, CEO of the hedge fund Pershing Square Capital, announced a bold and unusual move by partnering with pharmaceutical company, Valeant Pharmaceuticals International plc's cancer-drug business for $14.5 billion and will sell most of its vaccine business to GSK for $7.1 ... (more)
Meanwhile, Novartis also plans to sell its huge vaccine production facility in Holly Springs in a separate deal.
Drug maker Novartis says it has signed several multibillion-dollar deals with GlaxoSmithKline and Lilly that will affect some 15,000 of its employees.
PetMed Express Inc. is a leading nationwide pet pharmacy and Vet-VIPPS accredited, delivering prescription and non-prescription medications, and pet supplies.